Shares of Ses S.A. (OTCMKTS:SGBAF – Get Free Report) saw unusually-strong trading volume on Friday . Approximately 13,915 shares traded hands during trading, an increase of 379% from the previous session’s volume of 2,907 shares.The stock last traded at $9.89 and had previously closed at $9.70.
Analysts Set New Price Targets
Separately, New Street Research started coverage on SES in a research note on Wednesday, May 13th. They set a “neutral” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy”.
Read Our Latest Analysis on SES
SES Trading Up 0.3%
SES (OTCMKTS:SGBAF – Get Free Report) last released its quarterly earnings data on Tuesday, May 12th. The company reported $0.04 earnings per share (EPS) for the quarter. SES had a positive return on equity of 0.82% and a negative net margin of 4.96%.The business had revenue of $991.17 million for the quarter. On average, equities research analysts expect that Ses S.A. will post 0.05 EPS for the current fiscal year.
About SES
SES (OTCMKTS:SGBAF) is a leading global satellite operator headquartered in Betzdorf, Luxembourg. The company provides end-to-end satellite communications services, leveraging a fleet of geostationary satellites under the ASTRA and SES brands, as well as medium-earth orbit satellites through its O3b network. SES serves a diverse range of customers in the broadcast, telecom, maritime, aviation and government sectors, delivering managed video distribution and high-throughput data connectivity solutions worldwide.
The company’s video business enables broadcasters and content distributors to reach television audiences across Europe, North America, Latin America, Asia-Pacific and Africa.
Read More
- Five stocks we like better than SES
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for SES Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SES and related companies with MarketBeat.com's FREE daily email newsletter.
